Pharmacueticals

Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.

Shares of drug-maker Ranbaxy Laboratories fell by over 5 per cent in early trade on the BSE on Wednesday, despite the company posting an over five-fold jump in net profit for the year ending December 31, 2010. The drubbing on the bourses appears to be on account of the company's decision to only publish its earnings for the 2009-10 calendar...

Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.

Shares of drug-maker Ranbaxy Laboratories fell by over 5 per cent in early trade on the BSE on Wednesday, despite the company posting an over five-fold jump in net profit for the year ending December 31, 2010. The drubbing on the bourses appears to be on account of the company's decision to only publish its earnings for the 2009-10 calendar...